Evolva Holding (Evolva Holding) ROCE % : -220.84% (As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Evolva Holding ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Evolva Holding's annualized ROCE % for the quarter that ended in Jun. 2023 was -220.84%.

Evolva Holding ROCE % Historical Data

The historical data trend for Evolva Holding's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evolva Holding ROCE % Chart

Evolva Holding Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

-14.50

-11.18

-18.31

-27.11

-33.43

Evolva Holding Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROCE %	Get a 7-Day Free Trial															-34.45	-22.48	-41.86	-24.57	-220.84

Evolva Holding ROCE % Calculation

Evolva Holding's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	-45.734	/	( ( (169.569 - 16.527)	+	(140.626 - 20.036) )	/ 2 )
	=	-45.734	/	( (153.042	+	120.59)	/ 2 )
	=	-45.734	/	136.816
	=	-33.43 %

Evolva Holding's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Dec. 2022 )		(Q: Jun. 2023 )
	=	-175.594	/	( ( (140.626 - 20.036)	+	(59.015 - 20.583) )	/ 2 )
	=	-175.594	/	( ( 120.59	+	38.432 )	/ 2 )
	=	-175.594	/	79.511
	=	-220.84 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

Evolva Holding (OTCPK:ELVAF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Evolva Holding ROCE % Related Terms

Thank you for viewing the detailed overview of Evolva Holding's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Evolva Holding (Evolva Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Evolva Holding SA (OTCPK:ELVAF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

EVEz:UK EVE:Switzerland

Address

Duggingerstrasse 23, Reinach, CHE, CH-4153

Website

https://www.evolva.com

Evolva Holding SA en liquidation formerly Evolva Holding SA is a biotechnology company. The company is engaged in discovering, developing, and commercializing ingredients and biomanufacturing processes for nutrition, healthcare, and wellness products. Geographically, the company operates in Switzerland and the United States where Switzerland derives a majority of its revenue.

Evolva Holding (Evolva Holding) Headlines

From GuruFocus

Half Year 2023 Evolva Holding SA Earnings Call Transcript

By GuruFocus Research • 02-13-2024